Privi Speciality Chemicals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Mahesh Babani
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.7yrs |
| CEO ownership | 13.5% |
| Management average tenure | 4.4yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively
Nov 17
Some Confidence Is Lacking In Privi Speciality Chemicals Limited's (NSE:PRIVISCL) P/S
Oct 14Privi Speciality Chemicals Limited (NSE:PRIVISCL) Looks Just Right With A 28% Price Jump
Jun 25Privi Speciality Chemicals (NSE:PRIVISCL) Takes On Some Risk With Its Use Of Debt
Jun 04What Privi Speciality Chemicals Limited's (NSE:PRIVISCL) 25% Share Price Gain Is Not Telling You
Apr 30Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?
Sep 05These 4 Measures Indicate That Privi Speciality Chemicals (NSE:PRIVISCL) Is Using Debt Extensively
Mar 10Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?
Sep 21Privi Speciality Chemicals (NSE:PRIVISCL) Has A Somewhat Strained Balance Sheet
Jun 21Here's Why Privi Speciality Chemicals (NSE:PRIVISCL) Has A Meaningful Debt Burden
Feb 15Is Privi Speciality Chemicals (NSE:PRIVISCL) A Risky Investment?
May 24Trade Alert: The Independent Director Of Privi Speciality Chemicals Limited (NSE:PRIVISCL), Anurag Surana, Has Just Spent ₹9.9m Buying 200% More Shares
Feb 26Shareholders of Privi Speciality Chemicals (NSE:PRIVISCL) Must Be Delighted With Their 359% Total Return
Feb 24Does Privi Speciality Chemicals (NSE:PRIVISCL) Have A Healthy Balance Sheet?
Jan 31What To Know Before Buying Privi Speciality Chemicals Limited (NSE:PRIVISCL) For Its Dividend
Jan 16Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Jan 03
Is Privi Speciality Chemicals Limited's (NSE:PRIVISCL) Shareholder Ownership Skewed Towards Insiders?
Dec 21Read This Before Selling Privi Speciality Chemicals Limited (NSE:PRIVISCL) Shares
Dec 08If You Had Bought Privi Speciality Chemicals (NSE:PRIVISCL) Shares Five Years Ago You'd Have Earned 124% Returns
Nov 25Are Privi Speciality Chemicals's (NSE:PRIVISCL) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Nov 12Is It Smart To Buy Privi Speciality Chemicals Limited (NSE:PRIVISCL) Before It Goes Ex-Dividend?
Oct 21Privi Speciality Chemicals Limited (NSE:FAIRCHEM) Is An Attractive Dividend Stock - Here's Why
Oct 12Does Fairchem Speciality (NSE:FAIRCHEM) Have A Healthy Balance Sheet?
Sep 27A Piece Of The Puzzle Missing From Fairchem Speciality Limited's (NSE:FAIRCHEM) Share Price
Sep 14The Independent Director of Fairchem Speciality Limited (NSE:FAIRCHEM), Anurag Surana, Just Bought 400% More Shares
Aug 28Should We Be Excited About The Trends Of Returns At Fairchem Speciality (NSE:FAIRCHEM)?
Aug 18Is Fairchem Speciality Limited's (NSE:FAIRCHEM) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Aug 03Did Fairchem Speciality Limited (NSE:FAIRCHEM) Insiders Buy Up More Shares?
Jul 19Is Fairchem Speciality's (NSE:FAIRCHEM) Share Price Gain Of 120% Well Earned?
Jul 07Fairchem Speciality (NSE:FAIRCHEM) Is Growing Earnings But Are They A Good Guide?
Jun 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | n/a | n/a | ₹949m |
| Dec 31 2023 | n/a | n/a | ₹502m |
| Sep 30 2023 | n/a | n/a | ₹271m |
| Jun 30 2023 | n/a | n/a | ₹45m |
| Mar 31 2023 | ₹60m | ₹60m | ₹222m |
| Dec 31 2022 | n/a | n/a | ₹658m |
| Sep 30 2022 | n/a | n/a | ₹851m |
| Jun 30 2022 | n/a | n/a | ₹905m |
| Mar 31 2022 | ₹60m | ₹60m | ₹974m |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹50m | ₹50m | ₹1b |
Compensation vs Market: Insufficient data to establish whether Mahesh's total compensation is reasonable compared to companies of similar size in the Indian market.
Compensation vs Earnings: Mahesh's compensation has been consistent with company performance over the past year.
CEO
Mahesh Babani (66 yo)
7.7yrs
Tenure
₹60,000,000
Compensation
Mr. Mahesh Purshottambhai Babani serves as Chairman of the Board at Privi Speciality Chemicals Limited (formerly known as Fairchem Speciality Limited) since August 13, 2020. He has been Managing Director o...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 4.4yrs | ₹10.44m | no data | |
| Executive Director | 4.4yrs | ₹2.40m | 3.96% ₹ 2.8b | |
| MD & Chairman | no data | ₹60.00m | 13.54% ₹ 9.5b | |
| President | 4.4yrs | ₹20.33m | no data | |
| Group Company Secretary & Head Legal | 4.4yrs | no data | no data | |
| Company Secretary & Compliance Officer | 2.2yrs | no data | no data |
4.4yrs
Average Tenure
Experienced Management: PRIVISCL's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Director | 7.7yrs | ₹2.40m | 3.96% ₹ 2.8b | |
| MD & Chairman | 7.7yrs | ₹60.00m | 13.54% ₹ 9.5b | |
| Independent Non-Executive Director | 4.4yrs | ₹400.00k | no data | |
| Independent Non-Executive Director | 4.4yrs | ₹500.00k | 0.051% ₹ 36.0m | |
| Independent Non-Executive Woman Director | 4.4yrs | ₹500.00k | no data | |
| Independent Director | 7.7yrs | ₹150.00k | no data |
6.0yrs
Average Tenure
71yo
Average Age
Experienced Board: PRIVISCL's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 05:19 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Privi Speciality Chemicals Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Asian Markets Securities Private Limited |
| Kameswari V. S. Chavali | FirstCall Research |
| Chintan Modi | Haitong International Research Limited |